Launch in Denmark expands ColdZyme® to all of Scandinavia
Enzymatica, which develops and sells medical device products based on an enzyme from deep-sea cod, has signed agreements with the pharmacy chain Pharma+ and the wellness chain Matas in Denmark to sell ColdZyme® against common colds. From November this year, ColdZyme will be available on the Danish market, and thus in all of Scandinavia. "According to plan, we are expanding to our neighboring countries using our own sales organization, building a platform of close relationships with the pharmacy and wellness market throughout Scandinavia. The expanded geographic presence sets the scene